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Abstract The respiratory burst induced by phorbol myristate acetate in mouse macrophages was inhibited by ultra-low doses (10-Is-10 -~3 M) of 
an opioid peptide [D-Ala2]methionine enkephalinamide. The effect disappeared at concentrations above and below this range. The inhibition 
approached 50% and was statistically significant (P < 0.001). Increasing the time of the opioid incubation with ceils brought about a shift in the 
maximal effect o lower concentrations of the opioid (from 10 -~3 to 5.10 -15 M) and led to a decrease in the value of the effect, fully in accord with 
the previously proposed adaptation mechanism of the action of ultra-low doses. 
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1. Introduction 
The action of ultra-low doses (10-~8-10 -14 M) of opioid pep- 
tides on cells of the immune system have recently been observed 
in several laboratories [1-5]. The effects of ultra low doses 
(ULD) of biologically active substances are unusual because 
the concentration wherein a response is observed is 4 to 6 
orders lower than the lowest dissociation constants for l igand- 
receptor complexes (10-11-10 -~° M [6]). Another uncommon 
feature of the ULD effects is that they disappear with increasing 
the concentration of the acting substance (usually above 10 -1~- 
10 -9 M) [7,8]. In our recent paper [1] we have suggested a
possible mechanism of the ULD action which provides an ex- 
planation for all the main features of the ULD effects. Among 
other things, the hypothesis makes a prediction that the concen- 
tration whereby a maximal effect is observed has to be shifted 
to lower values as the time of incubation of the active substance 
with target cells is increased [1]. 
To verify this prediction and to further establish the very 
existence of the effects of opioids in ULD we studied the action 
of an opioid peptide (DAMEA)  on the respiratory burst in 
mouse peritoneal macrophages. The respiratory burst in mouse 
macrophages was significantly (up to about 50%) inhibited by 
ULD of DAMEA (10-15-10 -x3 M). The inhibitory effect of 
DAMEA was abolished by naloxone suggesting that the 
DAMEA action was mediated by specific opioid receptors. 
With increasing the time of DAMEA incubation with cells from 
10 to 30 min the maximal inhibitory effect on the dose depend- 
ence was shifted to lower concentrations (from about 10 -13 M 
to about 5" 10 -~5 M) and its value decreased, fully in accord with 
the predictions of our hypothesis. 
Sigma, naloxone and DAMEA were purchased from Peptide Institute 
Inc. (Japan), horseradish peroxidase was from Reakhim (Russian Fed- 
eration). HBSS (pH 7.4) was prepared from a concentrated stock solu- 
tion of HBSS (Sigma) without Phenol red and bicarbonate. 
2.2. Isolation of macrophages 
Peritoneal lavage from male mice of the CBA strain (18-20 g) was 
used as a source of resident peritoneal macrophages a described in [9]. 
The cells were resuspended in HBSS (at about 3" 106 cells/ml) and kept 
on ice (40°C). Luminescent studies were started after about a 2 h 
adaptation of the cells to post-isolation conditions. 
2.3. Luminescent studies 
The level of active oxygen generation by the macrophages was as- 
sayed by measuring the luminol-enhanced luminescence [10] in an LKB 
1251 luminometer. For further enhancing the response, horseradish 
peroxidase (10 -11 M) was also added to the solution. At this concentra- 
tion the peroxidase does not change the pattern of the respiratory burst 
and does not lead to self-activation fthe burst (without added PMA), 
but enhances the response by about 300%. Luminol (10 -6 M) and the 
peroxidase (10 -1~ M) were placed into a luminometer polystyrene cu- 
vette thermostated at 37°C under constant stirring; about 3" 106 cells 
(kept at 4°C prior to that) were added (final sample volume 1.2 ml) and 
spontaneous chemiluminescence was recorded for about 5 min; then 
DAMEA was added and the samples were incubated for I 0 or 30 min. 
Thereafter a stimulus (PMA, 10 -6 M) was added. The response was 
recorded in mV. In each experiment simultaneous readings from 
4 cuvettes were noted, two of them having control samples and the other 
two containing also the added effector (DAMEA). 
2.4. Data processing 
The experimental results obtained were processed using the Sigma- 
Plot v.4.0 program (Jandel Scientific) on IBM PC. Confidence intervals 
were determined by Student's t-test, the reliability of the effect was 
estimated also by the non-parametric sign test. 
3. Results and discussion 
2. Materials and methods 
2.1. Materials 
Phorbol 12-myristate 13-acetate (PMA) and luminol were from 
*Corresponding author. Fax: (7) (095) 939 3181. 
Abbreviations. DAMEA, [D-Ala2]methionine enkephalinamide; PMA, 
phorbol 12-myristate 13-acetate; ROS, reactive oxygen species. 
3.1. Inhibition of the respiratory burst at a constant ime of 
incubation of cells with DAMEA 
Typical examples of the time course of the respiratory burst 
in mouse macrophages (recorded as luminol-enhanced lumines- 
cence) induced by PMA in the presence and absence of 
DAMEA are presented in Fig. 1. A 10-min incubation with 
DAMEA in concentrations of 10-14-10 -13 M resulted in a de- 
crease both in the maximal rate of ROS generation (the maxi- 
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Fig. 1. The kinetic dependencies of the luminol-enhanced chemilumi- 
nescence (the respiratory burst) in mouse macrophages after adding the 
stimulus (PMA) at time t = 0.1 without DAMEA (1), and preincubated 
for 10 min with 10 -14 M DAMEA (2). 
mum on the curve) and in the total amount of reactive oxygen 
produced (the integral below the curve). 
Taking into account he observed variance in the value of the 
effect particular attention was given to the verification of the 
results. For each concentration of the opioid the experiment 
was repeated 10 -15 times. As can be seen in Fig. 2a, out of the 
studied DAMEA concentration range of 10-16-10  -7 M (10 min 
incubation with DAMEA) the inhibition (up to about 50%) 
occurred only at 10-~4-10 -13 M. The effect disappeared atcon- 
centrations above and below this narrow range. The observed 
dose-response r lationship is a bell-shaped dependence typical 
of the ULD effects. This relationship has also been found pre- 
viously in our experiments with human neutrophils [1,5]. The 
effects were much the same for the maximal rate of ROS gener- 
ation (Fig. 2a) and for the total amount of produced ROS (not 
shown). The inhibition by 10-~4-10 -13 M DAMEA was statisti- 
cally significant (P < 0.001). 
3.2. The adaptation mechanism of the action of opioid peptides 
and other biologically active substances in ultra-low doses 
In our recent paper [1] we proposed a possible mechanism 
of the ULD action. To gain a better understanding of the 
experimental results that follow, the hypothesis i briefly out- 
lined below. We took, as the starting point for the hypothesis, 
the fact that the effects of ULD of a certain active substance 
often emerge in the presence of a much higher concentration 
of the same substance. In particular, such is the case for opioids 
which are presented at an endogenous concentration of 10 -12-  
10 -1° M [1]. A cell is likely to adapt o the current concentration 
of the active substance and responds only to concentrational 
changes. Similar effects were observed in bacterial chemotaxis 
and interpreted by D.E. Koshland on the basis of the adapta- 
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tion mechanism involving simultaneous fast activation and 
slow inhibition of a certain key process by the active compound 
[11]. A schematic representation f the model is given in Fig. 
3. The ligand, L (active compound), acts on the transformations 
of factors (e.g. enzymes) El and E2 into their active forms (E' l ,  
E*2), which have opposite ffects (with different time constants) 
on the response, Z. From this scheme one can obtain the fol- 
lowing equation for the dependence of the effect, Z, on the 
concentration of the added active compound, C, and the time 
of incubation with this compound, t [1]: 
Z(t) = (LI(L + Kd) - LJ(Lo + Ka))" (e -k2(t+/cd)' - e kl(L+Kd)t) (1) 
where L0 is the initial concentration of the active compound, 
L = L0 + C is the concentration f the active compound after its 
addition, Ka = k_~lkl is the dissociation constant for the interac- 
tion of the active compound with factor El. 
This equation defines the bell-shaped dose-response d pend- 
encies typical for the ULD effects. From Eq. (1) it follows that 
as the time of incubation with the active compound increases 
the effect is shifted to lower concentrations and its value de- 
creases, as shown in Fig. 4. 
3.3. The shift in the dose dependence of the DAMEA effect 
with increasing the time of incubation is consistent with 
the proposed adaptation mechanism 
To verify the above-mentioned prediction of our hypothesis 
we repeated the experiments presented in Fig. 2a increasing the 
time of incubation with DAMEA from 10 to 30 min (Fig. 2b). 
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Fig. 2. The dose dependence of the DAMEA effect on the respiratory 
burst (inhibition of the maximal rate of ROS generation) in mouse 
macrophages. The bars represent mean _+ S.E.M. from 10 -t5 replicates. 
The time of incubation with DAMEA: (A) l0 min, (B) 30 min. 
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Separate xperiments revealed that incubation of cells without 
DAMEA at 37°C up to 30 min was without effect on the 
respiratory burst (not shown). As evident from Fig. 2a,b, the 
increased time of incubation with DAMEA led to a shift in the 
maximal effect o lower concentrations (from about 10 -13 M to 
5.10 -15 M) and to a decrease in the effect value (from about 
50% to 25%). This result is fully consistent with our prediction 
(compare Figs. 2 and 4). 
The antagonist of opioid receptors, naloxone, at 10 -7 M 
abolishes the inhibitory effect of 10 -14 M DAMEA (10 min 
incubation) on the respiratory burst: the effect decreases from 
48 + 7% to 6 + 2% (mean + S.E.M.) in the presence of nalox- 
one. Treatment with naloxone alone had no significant effect 
on the respiratory burst (not shown). As we have reported 
previously, amino acids, constituting DAMEA, do not affect 
the respiratory burst in human eutrophils when added at l 0  -14 
M [5]. These data indicate that the inhibitory effect of DAMEA 
is mediated by specific opioid receptors. 
In principle, the exact mechanism of opioid action could be 
different from the simplest one given in Fig. 3. Particularly, in 
order to obtain theoretical dependencies (Fig. 4), which coin- 
cide very closely with the experimental ones (Fig. 2), we had to 
use a Kd value of 10 -14 M, although for opioid receptors this 
value is about 10-1°-10 -9 M [12]. Therefore in this case Kd in 
our model may represent an 'apparent' value which is due to 
some additional system of signal amplification. 
In our view, the time-dependent shift shown in Fig. 2 pro- 
vides good evidence for the proposed adaptation mechanism of
the action of DAMEA in ULD, although it cannot be treated 
as a complete proof. Further consideration of the hypothesis 
requires us to determine the biochemical pathways involved in 
L 
E~ E2 
<'°"> qT" qT' 
EI~ E2 "~ 
>Z 
® ® 
Fig. 3. The scheme of the adaptation model of the ULD action. L = the 
ligand (active compound), E and E* = the nonactive and active forms 
of the regulatory factors (e.g. enzymes), k = the rate constants, Z = the 
observed effect. 
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Fig. 4. Theoretical dose dependencies of the relative ffect (Z) at differ- 
ent times of incubation (t) with an active compound. L0 = 0, k~ = 
101° M -~ "s -t, k_t = 10-4"s -1, kl/k2 = 2. (1) t = 10 min, (2) t = 30 min. 
the reported process of inhibition by DAMEA, possibly with 
the use of appropriate specific inhibitors. 
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